The IQVIA Institute recently released its annual report on the state of global Biopharma research and development (R&D) for the...
Quolet’s Phase 1 Study on Cannabidiol’s Safety and Bioavailability for Neurological and Psychiatric Diseases Completed – Insights from Medical Marijuana...
Experts Dismiss Cannabis and CBD as Effective Treatments for Glaucoma – Examining the Link to Medical Marijuana Programs Glaucoma is...
A Guide to Applying Infusions in Nightingale Infusions are a common medical procedure used in healthcare settings, including Nightingale hospitals,...
Samphire Neuroscience, a London-based company, has recently announced securing €2.1 million in funding to develop and introduce a groundbreaking wearable...
A Look into the Future: The Rise of Generative AI in 2024 Artificial Intelligence (AI) has been rapidly evolving over...
Parkinson’s disease is a neurodegenerative disorder that affects millions of people worldwide. It is characterized by the progressive loss of...
Clinical trials play a crucial role in advancing medical knowledge and improving patient care. They are essential for testing new...
The Similarities Between ADHD Medication and Meth: Unveiling the Big Pharma Double Standard Attention Deficit Hyperactivity Disorder (ADHD) is a...
FDA Approves First Cell Therapy for Solid Tumors, Marking a Significant Milestone In a groundbreaking development, the U.S. Food and...
A Comprehensive Guide to MDCG’s Clinical Investigations: Part 2 in the EU In the European Union (EU), the Medical Device...
Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...
The Potential of Cannabidiol as a Treatment for Different Substance Use Disorders Substance use disorders, including addiction to drugs and...
Cannabidiol (CBD) has been gaining popularity in recent years for its potential therapeutic benefits in treating a variety of health...
Florida House Panel Moves Forward with Legislation to Limit Hemp Cannabinoids In a move that has sparked controversy and debate,...
